| (Values in U.S. Thousands) | Sep, 2025 | Sep, 2024 | Sep, 2023 | Sep, 2022 | Sep, 2021 |
| Sales | 1,080,400 | 1,123,100 | 1,120,800 | 1,129,500 | 1,165,300 |
| Sales Growth | -3.80% | +0.21% | -0.77% | -3.07% | +7.35% |
| Net Income | 95,400 | 78,300 | 70,400 | 223,600 | 414,800 |
| Net Income Growth | +21.84% | +11.22% | -68.52% | -46.09% | -2.99% |
Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.
Fiscal Year End Date: 09/30